42 U.S.C. 284a; section 406 of the PHS Act, as amended. The Board is governed by the provisions of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees.

STRUCTURE

The Board shall consist of: (l) 18 members appointed by the President, and (2) 12 nonvoting ex officio members who shall include the Secretary; the Director of the Office of Science and Technology Policy; the Director of the National Institutes of Health, (NIH); the Chief Medical Director of the Department of Veterans Affairs; the Director of the National Institute for Occupational Safety and Health; the Director of the National Institute of Environmental Health Sciences; the Secretary of Labor; the Commissioner of the Food and Drug Administration; the Administrator of the Environmental Protection Agency; the Chairman of the Consumer Product Safety Commission; the Assistant Secretary of Defense for Health Affairs; and the Director of the Office of Energy Research of the Department of Energy (or their designees).

Not more than 12 of the appointed members shall be selected from among the leading representatives of the health and scientific disciplines (including not less than two individuals who are leaders in the fields of public health and the behavioral or social sciences) that are relevant to the activities of the Institute. Not more than six of the appointed members shall be representatives from the general public, including leaders in fields of public policy, law, health policy, economics and management. Not less than five of the appointed members shall be individuals knowledgeable in environmental carcinogenesis (including carcinogenesis involving occupational and dietary factors). A quorum for the conduct of business shall consist of a majority of currently appointed members.

Appointed members hold office for overlapping terms of six years and may not be reappointed before two years from the date of expiration of their term of office. Appointed members may serve after the expiration of their terms for 180 days after the date of expiration. Any member appointed to fill a vacancy occurring prior to expiration of the term for which that member's predecessor was appointed shall serve for the remainder of that term; however, persons appointed to complete an unexpired term of less than four years may be reappointed immediately for a full term following completion of that term. The President shall designate one of the appointed members to serve as Chair for a term of two years. In the absence of the Chair, the Director, NCI shall designate an Acting Chair from among the appointed members of the Board.

As necessary, subcommittees may be established to perform functions within the Board’s jurisdiction. The advice/recommendations of a subcommittee must be deliberated by the parent advisory committee. A subcommittee may not report directly to a Federal official unless there is statutory authority to do so.

Subcommittee membership may be drawn in whole or in part from the parent advisory committee. All subcommittee members may vote on subcommittee actions and all subcommittee members count towards the quorum for a subcommittee meeting. Ad hoc consultants do not count towards the quorum and may not vote. Subcommittee members who are not members of the parent committee may attend closed sessions of the parent committee meeting but they may not count towards the quorum of the parent committee and they cannot vote on committee actions.

Management and support services shall be provided by the Office of the Director, Division of Extramural Activities, National Cancer Institute.

FUNCTION

The Board shall advise, assist, consult with, and make recommendations to the Secretary and the Director, National Cancer Institute, with respect to the activities carried out by and through the Institute and policies respecting these activities; may recommend for support grants and cooperative agreements, following technical and scientific peer review; and relating to the functions pertaining to the NCI described under sections 405, 406, 413, and 414 of the PHS Act, as amended.

The Board may implement procedures for expediting en bloc concurrence of Scientific Review Group recommendations. A member or members may be selected by the Executive Secretary or Chair to provide en bloc concurrence on behalf of the Board. Only those applications that do not require individual consideration shall be included in this expedited process. A report of the en bloc recommendations will be presented at each Board meeting. .

MEETINGS

Meetings shall be held at the call of the Chair, or upon the request of the Director, NCI, not less than four times a year. A government official shall approve the agenda and shall be present at all meetings. The Board's operating procedures will be reviewed annually at the January/February meeting, as a part of the standard review of operating procedures, but may be reconsidered at any time at the call of the Chair.

Meetings shall be open to the public except as determined otherwise by the Secretary. Notice of all meetings shall be given to the public.

Meetings shall be conducted and records of the proceedings kept, as required by applicable laws and Departmental policies.